EDINBURG – Can a medical tool predict the risk of certain medications
based on a patient’s genetics, and, if so, could this information lead to doctors customizing a
patient’s drug therapy? The tool being studied at DHR Health Institute for Research &
Development to answer these questions is Cipherome’s Xentinel® Lighthouse, and this pilot study
will also evaluate the resulting savings in healthcare costs.
After a stroke or heart attack, the standard treatment is Percutaneous Coronary Intervention (PCI),
or stent placement. A stent opens blood vessels in the heart that have narrowed due to the buildup
of plaque. Following PCI, doctors typically prescribe aspirin and a P2Y12 ...